Metformin also reduces inflammation caused by obesity and insulin resistance by regulating Th17/Treg balance, intestinal flora, and NF-κB signaling pathway (77, 78). The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.